Annette Snejbjerg Bartels

Annette Snejbjerg Bartels


  1. 2015
  2. Published

    Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer : results from the WSG-AGO EC-Doc trial. / Erber, Ramona; Gluz, Oleg; Brünner, Nils; Kreipe, Hans Heinrich; Pelz, Enrico; Kates, Ronald; Bartels, Annette; Huober, Jens; Mohrmann, Svjetlana; Moustafa, Zehra; Liedtke, Cornelia; Möbus, Volker; Augustin, Doris; Thomssen, Christoph; Jänicke, Fritz; Kiechle, Marion; Kuhn, Walther; Nitz, Ulrike; Harbeck, Nadia; Hartmann, Arndt.

    In: Breast Cancer Research and Treatment, Vol. 150, No. 2, 04.2015, p. 279-288.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 6090964